Open Access
| Issue |
Med Sci (Paris)
Volume 41, Number 10, Octobre 2025
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 798 - 801 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2025144 | |
| Published online | 19 November 2025 | |
- Wachter F, Pikman Y. Pathophysiology of Acute Myeloid Leukemia. Acta Haematol 2024 ; 147 : 229–46. [Google Scholar]
- De Kouchkovsky I, Abdul-Hay M. ‘Acute myeloid leukemia: a comprehensive review and 2016 update’. Blood Cancer J 2016 ; 6 : e441. [Google Scholar]
- Liu S, Klisovic RB, Vukosavljevic T, et al. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells. J Pharmacol Exp Ther 2007 ; 321 : 953–60. [Google Scholar]
- Salmon JM, Todorovski I, Stanley KL, et al. Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML. Cancer Discov 2022 ; 12 : 1560–79. [Google Scholar]
- Schlenk RF, Krauter J, Raffoux E, et al. Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials. Haematologica 2018 ; 103 : e25–e8. [Google Scholar]
- Mithraprabhu S, Kalff A, Gartlan KH, et al. Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma. Br J Haematol 2021 ; 193 : 160–70. [Google Scholar]
- Alcitepe I, Salcin H, Karatekin I, Kaymaz BT. HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents’ combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model. Med Oncol 2022 ; 39 : 257. [Google Scholar]
- DiNardo CD, Wang J, Pratz KW. Azacitidine and Venetoclax in AML. Reply. N Engl J Med 2020 ; 383 : 2088–9. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.